Cyanofeed

Esox Biologics is a company dedicated to preventing the spread of infectious diseases among aquatic animals in the aquaculture industry. The company's core offering is a metagenomic analysis service that provides comprehensive insights into aquatic microbiomes. This technology uses next-generation DNA sequencing and bioinformatics to identify and characterize microorganisms in aquatic environments, including previously unknown species. Unlike traditional diagnostic methods that only detect known pathogens, Esox Biologics' approach can reveal the entire microbial population within a sample, offering a more holistic view of aquatic ecosystems.

The company's diagnostic services are designed to be implemented in surveillance programs, allowing aquaculture producers to regularly monitor their farms' microbiomes. This data helps farmers understand how their husbandry practices and environmental conditions affect microbial populations and potential disease threats. Esox Biologics is also developing a line of pathogen-inhibiting prebiotics, which are intended to be incorporated into existing feed formulations to modulate the microbiomes of aquatic livestock.

Esox Biologics' technology is applicable to various aquaculture settings, including indoor facilities, inland farms, and offshore operations. It caters to producers of different aquatic species, such as molluscs, finfish, and crustaceans, in diverse production formats like Recirculating Aquaculture Systems (RAS), raceways, and lined ponds. The company's services have been particularly valuable for RAS operators, providing insights into biofilter health and microbial community fluctuations that affect water quality and livestock well-being.